NCT07272044

Brief Summary

This study aims to propose a strategy for controlling the depth of anesthesia based on continuous and non-invasive monitoring of exhaled breath: BIS value during intravenous-inhalation combined anesthesia is predicted according to the real-time exhaled concentrations of sevoflurane and propofol, so as to achieve the depth of anesthesia management for patients who cannot use standard BIS. Furthermore, the relationship between anesthetic concentration and depth of anesthesia was analyzed in different subgroups.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
34mo left

Started Mar 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress45%
Mar 2024Mar 2029

Study Start

First participant enrolled

March 16, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

June 4, 2024

Completed
1.5 years until next milestone

First Posted

Study publicly available on registry

December 9, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2027

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2029

Last Updated

December 9, 2025

Status Verified

June 1, 2025

Enrollment Period

3 years

First QC Date

June 4, 2024

Last Update Submit

November 26, 2025

Conditions

Keywords

PropofolBreath testinganesthesia monitoringBispectral Indexintravenous and inhalational anesthesia

Outcome Measures

Primary Outcomes (2)

  • Correlation and consistency analysis between exhaled breath concentrations of two anesthetics and BIS values

    Correlation and consistency analysis between exhaled breath concentrations of two anesthetics detected by GC-SAW system and BIS values

    1 day

  • Establish a 3D drug dose-effect model of the exhaled concentration and BIS value of anesthetics

    Establish a 3D drug dose-effect model based on the exhaled gas concentration of anesthetics detected by the GC-SAW system and BIS value

    1day

Secondary Outcomes (2)

  • Correlation and consistency analysis of exhaled breath concentration and blood concentration of anesthetics

    1day

  • The incidence of adverse reactions

    72 hours

Study Arms (1)

Patients undergoing the first intravenous-inhalation combined anesthesia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who underwent general anesthesia for the first time and combined intravenous and inhalational anesthesia

You may qualify if:

  • Age ≥18 years old
  • ASA I-III
  • Expected duration of surgery \> 1 hour
  • Radial artery catheterization was performed
  • Patients requiring BIS monitoring.

You may not qualify if:

  • Patients with contraindications to general anesthesia
  • mental disorder, unable to answer
  • long-term use of antiepileptic drugs and psychotropic drugs
  • pregnant patients
  • patients refused to participate
  • patients who did not wake up in PACU

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Second Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Residual blood was analyzed by intraoperative blood gas analysis

Central Study Contacts

Fengjiang Zhang

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2024

First Posted

December 9, 2025

Study Start

March 16, 2024

Primary Completion (Estimated)

March 15, 2027

Study Completion (Estimated)

March 15, 2029

Last Updated

December 9, 2025

Record last verified: 2025-06

Locations